alexa Pulmonary hypertension: types and treatments.
Pulmonology

Pulmonology

Journal of Lung Diseases & Treatment

Author(s): RoseJones LJ, Mclaughlin VV

Abstract Share this page

Abstract Pulmonary arterial hypertension (PAH) is a panvasculopathy that affects the distal pulmonary arteries and leads to restricted blood flow. This increased afterload leads to adaptive mechanisms of the right ventricle, with eventual failure once it can no longer compensate. Pulmonary hypertension from associated conditions, most importantly left heart disease, i.e. heart failure, can also lead to the same sequela. Patients often experience early vague symptoms of dyspnea and exercise intolerance, and thus PH can elude clinicians until right heart failure symptoms predominate. Evidence-based treatment options with pulmonary vasodilators are available for those with PAH and should be employed early. It is essential that patients be accurately categorized by their etiology of PH, as treatment strategies differ, and can potentially be dangerous if employed in the wrong clinical scenario.
This article was published in Curr Cardiol Rev and referenced in Journal of Lung Diseases & Treatment

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 5th International Conference and Exhibition on Lung & Respiratory Care
    September 18-19, 2017 Jackson Ville, USA
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords